Today’s biosimilar landscape is characterized by rapid growth, intense competition, a diverse set of challenges, and large opportunities. As originator biologics go off patent, biotech companies are developing biosimilars to capture their share of a lucrative market. Sponsors aiming to capitalize on “first mover” advantages in major markets need an experienced partner with solutions to accelerate timelines and navigate a complex regulatory landscape. Read our fact sheet to learn more.